Cap-Translation Inhibitor, 4egi-1, Restores Sensitivity to ABT-737 Apoptosis Through Cap-Dependent and -Independent Mechanisms in Chronic Lymphocytic Leukemia

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-12-2185
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Chronic Lymphocytic Leukemia Requires BCL2 to Sequester Prodeath BIM, Explaining Sensitivity to BCL2 Antagonist ABT-737

Journal of Clinical Investigation
Medicine
2007English

Glycolysis Inhibition Targets McL-1 to Restore Sensitivity of Lymphoma Cells to ABT-737-induced Apoptosis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Anti-Rheumatic Agent Auranofin Induced Apoptosis in Chronic Myeloid Leukemia Cells Resistant to Imatinib Through Both BCR/Abl-Dependent and -Independent Mechanisms

Oncotarget
Oncology
2014English

ZGDHu-1 Promotes Apoptosis of Chronic Lymphocytic Leukemia Cells

International Journal of Oncology
Cancer ResearchOncology
2012English

Umbralisib and Carfilzomib Potently Inhibit Cap Dependent Translation in Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

The -45 Region of the Escherichia Coli Lac Promoter: CAP-dependent and CAP-independent Transcription.

Journal of Bacteriology
MicrobiologyMolecular Biology
1997English

Drug-Induced Apoptosis in Chronic Lymphocytic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1999English

Genome-Wide Profiling of Human Cap-Independent Translation-Enhancing Elements

Nature Methods
BiochemistryBiotechnologyCell BiologyMolecular Biology
2013English

The Cap-Dependent Translation Apparatus Integrates and Amplifies Cancer Pathways

RNA Biology
Cell BiologyMolecular Biology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy